tiprankstipranks
Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint
PremiumThe FlyZai Lab says partner Novocure’s Phase 3 trial met primary endpoint
2M ago
Zai Lab price target lowered to $66 from $123 at Citi
PremiumThe Fly
Zai Lab price target lowered to $66 from $123 at Citi
3M ago
Zai Lab Ltd’s New Share Price & Shareholder Rights Risk – A Cause for Worry?
PremiumCompany Announcements
Zai Lab Ltd’s New Share Price & Shareholder Rights Risk – A Cause for Worry?
3M ago
Zai Lab Secures Debt Facilities to Boost Capital Flexibility
PremiumCompany AnnouncementsZai Lab Secures Debt Facilities to Boost Capital Flexibility
3M ago
Zai Lab management to meet with Cantor Fitzgerald
PremiumThe Fly
Zai Lab management to meet with Cantor Fitzgerald
3M ago
Zai Lab management to meet with Cantor Fitzgerald
PremiumThe Fly
Zai Lab management to meet with Cantor Fitzgerald
3M ago
Paratek announces inclusion of oral NUZYRA in China’s NRDL
PremiumThe FlyParatek announces inclusion of oral NUZYRA in China’s NRDL
5M ago
Zai Lab announces updates on China NRDL
PremiumThe Fly
Zai Lab announces updates on China NRDL
5M ago
Zai Lab price target lowered to $123 from $128 at Citi
PremiumThe Fly
Zai Lab price target lowered to $123 from $128 at Citi
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100